| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040493A2 Schizophrenia associated gene, proteins and biallelic markers |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040466A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040464A1 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040451A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | WO2001040313A2 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 06/07/2001 | WO2001040312A2 Naive screening method |
| 06/07/2001 | WO2001040310A2 Immobilisation of proteins using a polypeptide segment |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040308A1 Dendritic cell-specific antibodies |
| 06/07/2001 | WO2001040307A1 Antibodies against signal regulator proteins |
| 06/07/2001 | WO2001040306A1 Human antibodies as detection reagents |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040292A1 Antigen-binding fragments specific for tumor associated antigens |
| 06/07/2001 | WO2001040290A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040277A2 Carbohydrate-aminated glycoproteins |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040271A2 Cancer associated antigens and uses therefor |
| 06/07/2001 | WO2001040270A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies |
| 06/07/2001 | WO2001040269A2 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | WO2001040268A2 Beryllofluoride analogues of acyl phosphate polypeptides |
| 06/07/2001 | WO2001040261A1 Method of diagnosing neurodegenerative disease |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001039806A1 Receptor binding conjugates |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001039796A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000074703B1 Therapeutic agent comprising a botulinum neurotoxin |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO2000009710A3 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | WO1998055629A3 A soybean peroxidase gene family and an assay for detecting soybean peroxidase activity |
| 06/07/2001 | CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2496312A1 Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2494705A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492070A1 Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492049A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491610A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491433A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491258A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490909A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490853A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2397731A1 Immunogen antivenom and vaccine against the venom of the black widow sp ider |
| 06/07/2001 | CA2396460A1 Protein-protein interactions |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393132A1 Dendritic cell-specific antibodies |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2393004A1 Method of diagnosing neurodegenerative disease |
| 06/07/2001 | CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2392939A1 Naive screening method |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392729A1 Human antibodies as detection reagents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392510A1 Compositions and methods for therapy and diagnosis of breast cancer |
| 06/07/2001 | CA2391455A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2388559A1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 06/07/2001 | CA2388205A1 Schizophrenia associated gene, proteins and biallelic markers |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
| 06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
| 06/06/2001 | EP1104772A1 Antibody for detecting microorganism |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104479A2 Method for recovering proteins from the interstitial fluid of plant tissues |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104470A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104442A1 Papillomavirus cellular receptor |
| 06/06/2001 | EP1104441A1 Hiv suppressor factor derived from scrub typhus |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104405A1 Near infrared chemiluminescent acridinium compounds and uses thereof |